how long have semaglutides been studied Variable weight-loss and cardiovascular benefits were seen with GLP-1 drugs in a systematic review and network meta-analysis, but effects on quality of life were less clear. https://www.medpagetoday.com/primarycare/obesity/122142 Diabetes Drug Could Help Reduce

Finally, there is a need to leverage multimodal clinical data beyond structured EHR findings to truly understand the holistic impact of GLP-1s with outcomes captured from different types of structured and unstructured data

During 2024 and 2025, the GLP-1 class was increasingly defined by expanded use cases and approvals, with existing drugs gaining indications including cardiovascular risk, sleep apnea and kidney disease

"Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-nave Subjects With Type 2 Diabetes (SUSTAIN 1)"

Blood glucose levels should be monitored before, during, and after exercise when starting an exercise regimen

A 2024 case series in Clinical Toxicology tracked three patients who accidentally injected 10 to 20 times their prescribed semaglutide dose